Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Shionogi & Co., Ltd.

November 2025

  • Home
  • Shionogi & Co., Ltd.

Shionogi & Co., Ltd. Market Share Analysis for November 2025

Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana. Shionogi has business roots that date back to 1878, and was incorporated in 1919.
Year Founded1878
Employees1001 - 5000
Annual Revenue> $1B
shionogi.com
shionogi-hc.co.jp
shionogi.co.jp
Shionogi & Co., Ltd.
Showing Shionogi & Co., Ltd.'s traffic and engagement information for its main website (including company regionals)
  • shionogi.co.jp
    shionogi.co.jp
  • shionogi.com
    shionogi.com
  • shionogi-hc.co.jp
    shionogi-hc.co.jp
See more website traffic and engagement information

Shionogi & Co., Ltd. Revenue up to November 2025 is > 1B

revenue generated by Shionogi & Co., Ltd. top domains

Shionogi & Co., Ltd. top domains revenue over 3 years

Revenue for Shionogi & Co., Ltd. top domains

shionogi.co.jpshionogi.co.jp> 1B
shionogi.comshionogi.com> 1B
shionogi-hc.co.jpshionogi-hc.co.jp> 1B
See more with Sales Intelligence

Shionogi & Co., Ltd. Stock price in November 2025

Shionogi & Co., Ltd. stock is traded under the ticker #4507. Below you can review Shionogi & Co., Ltd. stock performance in the past 12 months up to November 2025


Total visits to Shionogi & Co., Ltd.'s top domains

Understand Shionogi & Co., Ltd. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown
shionogi.co.jpshionogi.co.jp152.4K
shionogi.comshionogi.com688.5K
shionogi-hc.co.jpshionogi-hc.co.jp452.6K
See more with Sales Intelligence

Avg. visit duration in Shionogi & Co., Ltd.'s top domains

Analyze Shionogi & Co., Ltd. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
shionogi.co.jpshionogi.co.jp00:01:32
shionogi.comshionogi.com00:01:15
shionogi-hc.co.jpshionogi-hc.co.jp00:00:29
See more with Sales Intelligence

Avg. pageviews on Shionogi & Co., Ltd.'s top domains

See how Shionogi & Co., Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown
shionogi.co.jpshionogi.co.jp2.03
shionogi.comshionogi.com1.94
shionogi-hc.co.jpshionogi-hc.co.jp1.67
See more with Sales Intelligence

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Shionogi & Co., Ltd.

These are the website technologies, by industry, used by Shionogi & Co., Ltd. top domains

Payment & Currencies (21)

PayPal

PayPal

Advertising (4)

DoubleClick

DoubleClick

Marketing (3)

Google Marketing Platform

Google Marketing Platform

Recruitment (3)

iCIMS

iCIMS

More Technologies

10

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Shionogi & Co., Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsShionogi & Co. is developing novel pharmacologic therapies to treat OSA.Troutman Pepper client Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and other sleep disorders, announced a new joint venture with Shionogi & Co., Ltd., a leading global research-driven pharmaceutical company based in Japan, to develop novel pharmacologic therapies to treat OSA and other sleep disorders.
NewsSage Therapeutics, Inc. partners with Shionogi & Co..Sage Therapeutics, Inc. has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products.
NewsShionogi & Co. is developing products and services that support dementia care.By leveraging our respective strengths, PxDT and Shionogi plan to develop products and services that support dementia care in everyday life through stimulating senses such as sight and hearing, aiming to offer new solutions for people with dementia and society at large.

See all Shionogi & Co., Ltd. signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.